- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech High Return On Equity, Low Debt
Pakistani Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨124.9b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨389.53
7D
-1.1%
1Y
8.9%
Hoechst Pakistan
Market Cap: PK₨40.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,201.88
7D
0.2%
1Y
61.3%